# Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

> **NCT00570752** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 72 (actual)

## Conditions studied

- Vascular Diseases

## Interventions

- **OTHER:** Placebo
- **DRUG:** BMS-582949
- **DRUG:** Atorvastatin
- **DRUG:** Statin

## Key facts

- **NCT ID:** NCT00570752
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00570752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00570752, "Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00570752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*